Background: Nodular melanoma is the most dangerous form of melanoma and often evades early detection. Methods: We present a frequently traveling businessman whose nodular melanoma was detected by airport full body scanners. Results: For about 20 flights over 2 months, the airport full body scanners singled out an area on his left lower leg for a pat-down. Dermatologic examination discovered a nodular melanoma in this area, and after surgical excision, the man traveled without incident. Conclusion: This case raises the possibility of using full body imaging in the detection of melanomas, especially of the nodular subtype. In its current form, full body scanning would most likely not be sensitive or specific enough to become a recommended screening tool. Nonetheless, for travelers with areas repeatedly singled out by the machines without a known justification, airport scanners could serve as incidental free screening for suspicious nodular lesions that should prompt dermatologist referral.

Journal Section:
Editor's choice
Keywords:
Melanoma, Nodular melanoma, Early detection, Screening, Diagnostic imaging
1.
Geller AC, Swetter SM, Brooks K, Demierre MF, Yaroch AL: Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions. J Am Acad Dermatol 2007;57:555-572.
[PubMed]
https://doi.org/10.1016/j.jaad.2007.06.032
2.
Shaikh WR, Xiong M, Weinstock MA: The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007. Arch Dermatol 2012;148:30-36.
[PubMed]
https://doi.org/10.1001/archdermatol.2011.264
3.
Warycha MA, Christos PJ, Mazumdar M, Darvishian F, Shapiro RL, Berman RS, Pavlick AC, Kopf AW, Polsky D, Osman I: Changes in the presentation of nodular and superficial spreading melanomas over 35 years. Cancer 2008;113:3341-3348.
[PubMed]
https://doi.org/10.1002/cncr.23955
4.
Transportation Security Administration: AIT: How it works. 2013. http://www.tsa.gov/ait-how-it-works (accessed June 29, 2014).
5.
MELA-Sciences: About MelaFind. 2014. http://www.melasciences.com/melafind (accessed June 29, 2014).
6.
Monheit G, Cognetta AB, Ferris L, Rabinovitz H, Gross K, Martini M, Grichnik JM, Mihm M, Prieto VG, Googe P, King R, Toledano A, Kabelev N, Wojton M, Gutkowicz-Krusin D: The performance of MelaFind: a prospective multicenter study. Arch Dermatol 2011;147:188-194.
[PubMed]
https://doi.org/10.1001/archdermatol.2010.302
7.
Moulder JE: Risks of exposure to ionizing and millimeter-wave radiation from airport whole-body scanners. Radiat Res 2012;177:723-726.
[PubMed]
https://doi.org/10.1667/RR2897.1
© 2014 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2014
You do not currently have access to this content.